US 6936719
Biaryl compounds as serine protease inhibitors
expired A61KA61K31/192A61K31/341
Quick answer
US patent 6936719 (Biaryl compounds as serine protease inhibitors) held by BioCryst Pharmaceuticals, Inc. expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/192, A61K31/341, A61K31/381, A61K31/426